Fatal Cardiac Hemochromatosis in a Patient with Hereditary Spherocytosis

  • Fujino Takeo
    Department of Cardiovascular Medicine, Kyushu University Hospital
  • Inoue Shujiro
    Department of Cardiovascular Medicine, Kyushu University Hospital
  • Katsuki Shunsuke
    Department of Cardiovascular Medicine, Kyushu University Hospital
  • Higo Taiki
    Department of Cardiovascular Medicine, Kyushu University Hospital
  • Ide Tomomi
    Department of Cardiovascular Medicine, Kyushu University Hospital
  • Oda Yoshinao
    Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University
  • Tsutsui Hiroyuki
    Department of Cardiovascular Medicine, Kyushu University Hospital

Search this article

Description

<p>A 31-year-old man was admitted to our hospital with atrial tachycardia and cardiogenic shock. He had been diagnosed with hereditary spherocytosis (HS) during childhood, but he never received any red blood cell transfusions. Right ventricular endomyocardial biopsy revealed multiple myocardial hemosiderin deposits, and he was diagnosed with cardiac hemochromatosis. In addition to the iron deposition in the heart, the loss of myocyte and severe interstitial fibrosis were present. His cardiac function did not improve even after the cardioversion for atrial tachycardia, and he suffered from recurrent heart failure. Despite intensive medical treatment for heart failure and arrhythmias in combination with iron chelation therapy, he eventually died of progressive and refractory heart failure. Hemochromatosis is a systemic disorder characterized by the excessive deposition of iron in multiple organs. The occurrence of hemochromatosis in HS is extremely rare, and previous reports have shown that the coexistence of heterozygosity for the HFE gene mutation in HS patients causes excess iron storage. The prognosis is poor due to progressive congestive heart failure and refractory arrhythmias. Here we report a rare case of fatal cardiac hemochromatosis associated with HS. The possibility of cardiac hemochromatosis needs to be considered in cases of heart failure or arrhythmia in patients with HS.</p>

Journal

Citations (1)*help

See more

References(8)*help

See more

Details 詳細情報について

Report a problem

Back to top